샘플 요청 목록

 카트 문의
시장보고서
상품코드
1776208

세계의 일회용 내시경 시장 : 시장 인사이트, 경쟁 구도 시장 예측(2032년)

Disposable Endoscopes - Market Insights, Competitive Landscape, and Market Forecast - 2032
발행일: | 리서치사: DelveInsight | 페이지 정보: 영문 150 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

세계의 일회용 내시경 시장 규모는 2024년에 26억 5,844만 달러로, 2032년까지 57억 4,875만 달러에 달할 것으로 예측되며, 2025-2032년의 예측 기간에 CAGR로 10.19%의 성장이 전망됩니다. 의료 환경의 2차 오염과 감염이 증가함에 따라 일회용 내시경과 같이 재처리가 필요 없고 감염 위험을 줄일 수 있는 안전한 대체품에 대한 수요가 증가하고 있습니다. 또한 소화기 질환, 호흡기 질환, 비뇨기 질환 등 만성질환 증가로 진단 및 치료를 목적으로 하는 내시경 시술이 증가하고 있습니다. 또한 이미징, 휴대성, AI 통합의 진보를 포함한 지속적인 제품 개발 활동은 기기의 성능과 사용 편의성을 향상시키고 있습니다. 이러한 요인들은 2025-2032년의 예측 기간 중 일회용 내시경 세계 시장 성장을 크게 촉진하고 있습니다.

일회용 내시경 시장 역학

세계보건기구(WHO)(2022)의 데이터에 따르면 급성기 병원에 입원한 환자 100명당 고소득 국가에서는 약 7명, 중저소득 국가에서는 약 15명이 입원 기간 중 최소 1회 이상 의료 관련 감염(HAI)을 경험하고 있습니다. 또한 이 보고서는 항생제가 듣지 않는 의료 관련 감염이 전 세계에서 매년 약 1억 3,600만 건이 발생하는 것으로 추정하고 있습니다.

재사용 가능한 내시경은 재처리가 이루어지고 있음에도 불구하고 클로스트리디움 디피실, 녹농균, MRSA, VRE, CRE와 같은 약물 내성균과 같은 감염을 전파할 수 있는 심각한 위험을 여전히 내포하고 있습니다. 반면, 일회용 내시경은 무균, 일회용 솔루션으로 소독 실패의 위험을 제거합니다. 따라서 중환자실(ICU), 응급실 등 위험도가 높은 환경에 특히 적합합니다. 따라서 감염 관리의 향상과 보다 안전하고 효율적인 임상 실습에 대한 요구가 일회용 내시경 수요의 확대를 촉진하고 있습니다.

또한 호흡기, 소화기, 비뇨기 질환의 유병률 증가는 일회용 내시경 시장을 더욱 견인하고 있습니다. World Gastroenterology Organization(2023)에 따르면 전 세계 여성의 약 49%, 남성의 36.6%가 적어도 한 가지 이상의 기능성 위장장애 기준을 충족하고 있습니다. 마찬가지로 Urology Foundation(2023)의 데이터에 따르면 영국에서는 약 2명 중 1명이 비뇨기 질환을 경험하고 있습니다. 이러한 유병률 증가는 진단 및 치료 시술에 대한 수요 증가에 기여하고 있으며, 일회용 내시경 솔루션의 필요성을 높이고 있습니다.

재사용 가능한 내시경은 효과적이지만, 복잡하고 시간과 비용이 많이 드는 재처리 프로토콜이 필요하며 교차 오염의 위험이 있습니다. 외래수술센터(ASC)와 응급실에서 내시경 시술이 증가함에 따라 일회용 내시경은 실용적인 대안을 제공합니다. 일회용 내시경은 감염 위험을 줄이고, 소요 시간을 단축하며, 환자 처리 능력을 향상시킵니다.

또한 업계 주요 기업의 지속적인 제품 개발 활동이 시장 확대를 지원하고 있습니다. 예를 들어 2022년 5월 암부는 무균 일회용 기관지 내시경 제품인 암부(R)aScope(TM)5 Broncho에 대한 유럽 규제 당국의 승인을 획득했습니다.

따라서 위의 요인은 2025-2032년의 예측 기간 중 일회용 내시경 시장의 성장을 전반적으로 촉진할 것으로 예측됩니다.

그러나 이러한 장점에도 불구하고 특정 제한이 시장 성장의 걸림돌이 될 수 있습니다. 일회용 내시경은 일회용 기기이기 때문에 의료 폐기물을 발생시켜 환경과 지속가능성에 대한 우려가 커지고 있습니다. 또한 복잡한 시술에 대한 적합성이 제한적이기 때문에 일부 임상 환경에서 채택이 제한될 수 있으며, 이는 더 넓은 시장 확대에 대한 주요 억제요인으로 작용할 수 있습니다.

북미가 전체 일회용 내시경 시장을 독점할 것으로 예측됩니다.

북미는 의료 관련 감염(HAI) 발병률 증가, 비뇨기 및 소화기 질환과 같은 만성질환의 유병률 증가, 의료 기술의 지속적인 발전 등 여러 요인으로 인해 2024년 세계 일회용 내시경 시장을 주도할 것으로 예측됩니다.

세계의 일회용 내시경 시장에 대해 조사분석했으며, 시장 규모와 예측, 과거 3년 제품/서비스 개발, 시장의 주요 기업, 이용 가능한 기회 등의 정보를 제공하고 있습니다.

목차

제1장 일회용 내시경 시장 보고서 서론

제2장 일회용 내시경 시장 개요

  • 시장의 개요

제3장 경쟁 구도

제4장 규제 분석

  • 미국
  • 유럽
  • 일본
  • 중국

제5장 일회용 내시경 시장의 주요 요인 분석

  • 일회용 내시경 시장 촉진요인
  • 일회용 내시경 시장 억제요인과 과제
  • 일회용 내시경 시장의 기회

제6장 일회용 내시경 시장 : Porter's Five Forces 분석

제7장 일회용 내시경 시장 평가

  • 제품별
    • 기관지경
    • 위카메라
    • 십이지장 내시경
    • 후두경
    • 기타
  • 용도별
    • 호흡기과
    • 소화기과
    • 비뇨기과
    • 이비인후과
  • 최종사용자별
    • 병원·진료소
    • 외래 수술 센터
  • 지역
    • 북미
    • 유럽
    • 아시아태평양
    • 기타 지역

제8장 일회용 내시경 시장의 기업과 제품 개요

  • Olympus Corporation
  • Boston Scientific Corporation
  • Ambu Inc.
  • ProSurg Inc.
  • Baxter
  • Teleflex Incorporated
  • Flexicare Medical Limited
  • AUG Medical
  • NeoScope Inc
  • Xenocor Inc.
  • 3NT Medical
  • Corinth MedTech, Inc.
  • PENTAX Medical
  • Daichuan medical
  • Omnivision
  • Verathon

제9장 KOL의 견해

제10장 프로젝트 어프로치

제11장 DelveInsight 소개

제12장 면책사항, 문의

KSA 25.07.31

Disposable Endoscopes Market by Product (Bronchoscopes, Gastroscopes, Duodenoscopes, Laryngoscope, and Others), Application (Pulmonology, Gastroenterology, Urology, ENT, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the increasing instances of cross-contamination and infections, increasing prevalence of chronic conditions, and rising product developmental activities globally.

The disposable endoscopes market was valued at USD 2,658.44 million in 2024, growing at a CAGR of 10.19% during the forecast period from 2025 to 2032 to reach USD 5,748.75 million by 2032. The increasing instances of cross-contamination and infections in healthcare settings are driving the demand for safer alternatives like disposable endoscopes, which eliminate the need for reprocessing and reduce infection risks. Alongside this, the rising prevalence of chronic conditions such as gastrointestinal, respiratory, and urological disorders is leading to a higher volume of diagnostic and therapeutic endoscopic procedures. Additionally, ongoing product development activities, including advancements in imaging, portability, and AI integration, are enhancing device performance and usability. Collectively, these factors are significantly boosting the overall market growth of disposable endoscopes worldwide during the forecast period from 2025 to 2032.

Disposable Endoscopes Market Dynamics:

According to data from the World Health Organization (2022), for every 100 patients admitted to acute-care hospitals, approximately 7 in high-income countries and 15 in low- and middle-income countries acquire at least one healthcare-associated infection (HAI) during their hospital stay. Furthermore, the same report estimates that around 136 million cases of healthcare-associated, antibiotic-resistant infections occur globally each year.

Reusable endoscopes, despite undergoing reprocessing, continue to pose a significant risk of transmitting infections such as Clostridioides difficile, Pseudomonas aeruginosa, and drug-resistant organisms like MRSA, VRE, and CRE. In contrast, disposable endoscopes offer a sterile, single-use solution that eliminates the risk of disinfection failures. This makes them particularly suitable for high-risk environments such as intensive care units (ICUs) and emergency departments. Consequently, the need for improved infection control and safer, more efficient clinical practices is fueling the growing demand for disposable endoscopes.

In addition, the increasing prevalence of respiratory, gastrointestinal, and urological conditions is further driving the disposable endoscope market. According to the World Gastroenterology Organization (2023), approximately 49% of females and 36.6% of males globally meet the criteria for at least one functional gastrointestinal disorder. Similarly, data from the Urology Foundation (2023) indicate that around one in two individuals in the United Kingdom experiences a urological condition. These rising disease rates are contributing to increased demand for diagnostic and therapeutic procedures, thereby boosting the need for disposable endoscopic solutions.

While reusable endoscopes are effective, they require complex, time-consuming, and costly reprocessing protocols, which also carry a risk of cross-contamination. With a growing number of endoscopic procedures being performed in outpatient settings, ambulatory surgical centers, and emergency departments, disposable endoscopes offer a practical alternative. They reduce infection risk, shorten turnaround times, and enhance patient throughput.

Moreover, ongoing product development efforts by key industry players are supporting market expansion. For example, in May 2022, Ambu received European regulatory approval for its Ambu(R) aScope(TM) 5 Broncho, a line of sterile, single-use bronchoscopes.

Therefore, the factors outlined above are expected to collectively drive the growth of the disposable endoscopes market during the forecast period from 2025 to 2032.

However, despite these advantages, certain limitations could hinder market growth. As single-use devices, disposable endoscopes contribute to medical waste, raising environmental and sustainability concerns. Additionally, their limited suitability for complex procedures may restrict adoption in some clinical settings, serving as key constraints on broader market expansion.

Disposable Endoscopes Market Segment Analysis:

Disposable Endoscopes Market by Product (Bronchoscopes, Gastroscopes, Duodenoscopes, Laryngoscope, and Others), Application (Pulmonology, Gastroenterology, Urology, ENT, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the products segment of disposable endoscopes, the bronchoscopes category is expected to have a significant revenue share in the year 2024. This can be ascribed to their advantages, such as the use of bronchoscopes in the diagnosis and treatment of tumors and bronchial cancers, airway blockage (obstruction), narrowed areas in the airways, and interstitial pulmonary diseases, among others.

Another key aspect contributing in the growing demand for bronchoscopes is that it also comprises of increased detection and improved access, reaching to the most distant regions of the lungs, earlier diagnosis of lung tumors, better treatment decisions, reduced risk associated with complications, and eliminating the risk associated with invasive surgeries, all of the advantages possible due to the presence of navigational bronchoscopy.

Given the advantages associated with navigational bronchoscopy, there has been increasing acceptance among end users, which in turn has led to a rise in the number of new product launches in the market. For example, in April 2023, Verathon, a leading global medical device company, announced the launch of the BFlex(TM) 2, the next generation of its single-use bronchoscope portfolio. The upgraded BFlex 2 series features four scope sizes and incorporates enhanced capabilities aimed at helping clinicians deliver improved care for both adult and pediatric patients across various hospital settings.

Therefore, driven by these advancements and growing clinical adoption, the bronchoscopes segment is anticipated to experience significant growth, thereby contributing substantially to the overall expansion of the disposable endoscopes market during the forecast period from 2025 to 2032.

North America is expected to dominate the overall disposable endoscopes market:

North America is expected to lead the global disposable endoscopes market in 2024, driven by several key factors, including the rising incidence of healthcare-associated infections (HAIs), the growing prevalence of chronic conditions such as urological and gastrointestinal disorders, and continued advancements in healthcare technology.

One of the primary drivers in the region is the increasing risk of cross-contamination associated with reusable endoscopes. According to data from the Centers for Disease Control and Prevention (CDC, 2024), approximately 1 in 31 hospital patients in the United States acquires at least one healthcare-associated infection. Similarly, recent data from the Provincial Infection Control Network of British Columbia (2025) reported that in Canada, 1 in 9 hospital patients contract an HAI, with over 220,000 such cases occurring annually. These statistics underscore the growing threat of infection in clinical settings, especially where reusable devices are used. Disposable endoscopes, being sterile and single-use, eliminate the risk of cross-contamination and are increasingly preferred in high-risk environments such as ICUs and emergency departments.

Additionally, technological innovations and regulatory support are strengthening the regional market. North America has witnessed a surge in product development and regulatory approvals, supported by a well-established healthcare infrastructure and the strong presence of key medical device companies. These conditions create a favorable ecosystem for market expansion.

For example, in May 2024, Olympus Corporation announced the launch of the DVM-B2 Digital Video Monitor, an integrated video processor and monitor specifically designed for use with single-use endoscopes. This system supports applications in bronchoscopy and ENT procedures and is compatible with Olympus's H-SteriScope(TM) Single-use Flexible Bronchoscopes and E-SteriScope(TM) Single-use Flexible Rhinolaryngoscopes. The device, manufactured by Hunan Vathin Medical Instruments Co., Ltd., is distributed exclusively by Olympus America, Inc., further reinforcing the company's commitment to advancing disposable endoscopy solutions in the region.

Moreover, increased awareness of infection control, favorable reimbursement frameworks, and ongoing partnerships and commercialization strategies among major industry players are expected to accelerate market growth further.

In conclusion, the convergence of rising HAI rates, technological innovation, growing demand for safer diagnostic tools, and strong regional healthcare investment is expected to make North America a dominant force in the disposable endoscopes market during the forecast period from 2025 to 2032.

Disposable Endoscopes Market key players:

Some of the key market players operating in the disposable endoscopes market include Olympus Corporation, Boston Scientific Corporation, Ambu Inc., ProSurg Inc., Baxter, Teleflex Incorporated, Flexicare Medical Limited, AUG Medical, NeoScope Inc., Xenocor Inc., 3NT Medical, Corinth MedTech, Inc., PENTAX Medical, Daichuan Medical, Omnivision, Verathon, and others.

Recent Developmental Activities in the Disposable Endoscopes Market:

  • In September 2023, Olympus Corporation launched the Vathin E-SteriScope single-use flexible video rhinolaryngoscope for use in diagnostic and therapeutic otorhinolaryngological procedures.
  • In April 2023, Verathon, a global leader in airway management solutions, unveiled the GlideScope(R) Spectrum(TM) QC featuring QuickConnect(TM) technology. This extensive lineup of single-use video laryngoscopes showcases a magnetic connector coupled with improvements in image quality, designed to support rapid and effective airway management.
  • In November 2022, PROACT Medical launched a new range of gas sampling lines along with their new line of single-use laryngoscopes to improve patient care in the European market.

Key takeaways from the disposable endoscopes market report study:

  • Market size analysis for current disposable endoscopes market size (2024), and market forecast over 8 years (2025 to 2032)
  • Top key product/services developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
  • Key companies dominating the disposable endoscopes market
  • Various opportunities available for the other competitors in the disposable endoscopes market space
  • What are the top-performing segments in 2024? How these segments will perform in 2032?
  • Which are the top-performing regions and countries in the current disposable endoscopes market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for the disposable endoscopes market growth in the future?

Target audience who can benefit from this disposable endoscopes market report study:

  • Disposable endoscopes product providers
  • Research organizations and consulting companies
  • Disposable endoscopes-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in disposable endoscopes
  • Various end-users who want to know more about the disposable endoscopes market and the latest developments in the disposable endoscopes market

Frequently Asked Questions for the Disposable Endoscopes Market:

1. What are disposable endoscopes?

  • The disposable endoscopes, also known as single-use endoscopes, are medical devices designed to perform minimally invasive diagnostic and therapeutic procedures within the body. Unlike reusable endoscopes, they are discarded after a single use, eliminating the need for sterilization and reprocessing.

2. What is the market for disposable endoscopes?

  • The disposable endoscopes market was valued at USD 2,658.44 million in 2024, growing at a CAGR of 10.19% during the forecast period from 2025 to 2032 to reach USD 5,748.75 million by 2032.

3. What are the drivers for the disposable endoscopes market?

  • The increasing instances of cross-contamination and infections in healthcare settings are driving the demand for safer alternatives like disposable endoscopes, which eliminate the need for reprocessing and reduce infection risks. Alongside this, the rising prevalence of chronic conditions such as gastrointestinal, respiratory, and urological disorders is leading to a higher volume of diagnostic and therapeutic endoscopic procedures. Additionally, ongoing product development activities, including advancements in imaging, portability, and AI integration, are enhancing device performance and usability. Collectively, these factors are significantly boosting the overall market growth of disposable endoscopes worldwide during the forecast period from 2025 to 2032.

4. Who are the key players operating in the disposable endoscopes market?

  • Some of the key market players operating in the disposable endoscopes market include Olympus Corporation, Boston Scientific Corporation, Ambu Inc., ProSurg Inc., Baxter, Teleflex Incorporated, Flexicare Medical Limited, AUG Medical, NeoScope Inc., Xenocor Inc., 3NT Medical, Corinth MedTech, Inc., PENTAX Medical, Daichuan Medical, Omnivision, Verathon, and others.

5. Which region has the highest share in the disposable endoscopes market?

  • Among all the regions, North America is expected to dominate the disposable endoscopes market in the year 2024. This can be attributed to several factors, such as rising instances of cross-contamination and chronic conditions such as urological and gastrointestinal disorders. Additionally, the enhanced technological advancements, regulatory approvals, and significant market presence of leading companies, continued investment in healthcare infrastructure, and innovative product developments are other major factors that are expected to drive the market for disposable endoscopes during the forecast period from 2025 to 2032.

Table of Contents

1. Disposable Endoscopes Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Disposable Endoscopes Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Disposable Endoscopes Market Key Factors Analysis

  • 5.1. Disposable Endoscopes Market Drivers
    • 5.1.1. Increasing instances of cross-contamination and infections
    • 5.1.2. Increasing instances of chronic conditions
    • 5.1.3. Rising product development activities globally
  • 5.2. Disposable Endoscopes Market Restraints and Challenges
    • 5.2.1. Raising concerns about the environmental impact
    • 5.2.2. Limitations associated with devices
    • 5.2.3. Stringent regulations for some of the single-use endoscopes
  • 5.3. Disposable Endoscopes Market Opportunities
    • 5.3.1. Integration with imaging and navigation technologies

6. Disposable Endoscopes Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Disposable Endoscopes Market Assessment

  • 7.1. By Product
    • 7.1.1. Bronchoscopes
    • 7.1.2. Gastroscopes
    • 7.1.3. Dudenoscopes
    • 7.1.4. Laryngoscopes
    • 7.1.5. Others
  • 7.2. By Application
    • 7.2.1. Pulmonology
    • 7.2.2. Gastroenterology
    • 7.2.3. Urology
    • 7.2.4. ENT
    • 7.2.5. Others
  • 7.3. By End-User
    • 7.3.1. Hospitals & Clinics
    • 7.3.2. Ambulatory Surgical Centers
    • 7.3.3. Others
  • 7.4. By Geography
    • 7.4.1. North America
      • 7.4.1.1. United States Disposable Endoscopes Market Size in USD million (2022-2033)
      • 7.4.1.2. Canada Disposable Endoscopes Market Size in USD million (2022-2033)
      • 7.4.1.3. Mexico Disposable Endoscopes Market Size in USD million (2022-2033)
    • 7.4.2. Europe
      • 7.4.2.1. France Disposable Endoscopes Market Size in USD million (2022-2033)
      • 7.4.2.2. Germany Disposable Endoscopes Market Size in USD million (2022-2033)
      • 7.4.2.3. United Kingdom Disposable Endoscopes Market Size in USD million (2022-2033)
      • 7.4.2.4. Italy Disposable Endoscopes Market Size in USD million (2022-2033)
      • 7.4.2.5. Spain Disposable Endoscopes Market Size in USD million (2022-2033)
      • 7.4.2.6. Rest of Europe Disposable Endoscopes Market Size in USD million (2022-2033)
    • 7.4.3. Asia-Pacific
      • 7.4.3.1. China Disposable Endoscopes Market Size in USD million (2022-2033)
      • 7.4.3.2. Japan Disposable Endoscopes Market Size in USD million (2022-2033)
      • 7.4.3.3. India Disposable Endoscopes Market Size in USD million (2022-2033)
      • 7.4.3.4. Australia Disposable Endoscopes Market Size in USD million (2022-2033)
      • 7.4.3.5. South Korea Disposable Endoscopes Market Size in USD million (2022-2033)
      • 7.4.3.6. Rest of Asia-Pacific Disposable Endoscopes Market Size in USD million (2022-2033)
    • 7.4.4. Rest of the World (RoW)
      • 7.4.4.1. Middle East Disposable Endoscopes Market Size in USD million (2022-2033)
      • 7.4.4.2. Africa Disposable Endoscopes Market Size in USD million (2022-2033)
      • 7.4.4.3. South America Disposable Endoscopes Market Size in USD million (2022-2033)

8. Disposable Endoscopes Market Company and Product Profiles

  • 8.1. Olympus Corporation
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Boston Scientific Corporation
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Ambu Inc.
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. ProSurg Inc.
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. Baxter
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. Teleflex Incorporated
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. Flexicare Medical Limited
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. AUG Medical
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. NeoScope Inc
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. Xenocor Inc.
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. 3NT Medical
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Corinth MedTech, Inc.
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. PENTAX Medical
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. Daichuan medical
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. Omnivision
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy
  • 8.16. Verathon
    • 8.16.1. Company Overview
    • 8.16.2. Company Snapshot
    • 8.16.3. Financial Overview
    • 8.16.4. Product Listing
    • 8.16.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제